Instalab
logoInstalab

OGTT with Insulin (3 hour, 7 Specimens)

Blood Test
Glucose and insulin with 7 timepoints, providing an in-depth analysis of glucose metabolism and insulin response over 3 hours.
4.9 (2,677 reviews)
Tested by Quest Diagnostics
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At 2,000+ patient service centers · 8-hour fast required
Get results
Explained with clear next steps, no medical jargon

Should you take a OGTT with Insulin (3 hour, 7 Specimens) test?

This test is most useful if any of these apply to you.

Family History of Diabetes
You want to know whether your insulin system is already compensating quietly, decades before standard testing would notice.
Stubborn Weight Around the Middle
Central weight gain often tracks with hidden insulin resistance long before fasting glucose ever budges out of range.
Post-Meal Energy Crashes
Shakiness, hunger, or brain fog two to three hours after eating often shows up on the late part of the curve.
Healthy but Want the Earliest Read
Your fasting numbers look fine and you want the sharpest possible picture of how your body actually handles sugar.

14 Biomarkers Included

About OGTT with Insulin (3 hour, 7 Specimens)

Fasting glucose and HbA1c are the last dominoes to fall. By the time either one drifts out of range, your pancreas has often spent a decade quietly pumping out two, three, even five times the normal amount of insulin to keep your blood sugar looking respectable on paper. This panel catches that hidden compensation in the act.

You drink a measured sugar load, then have blood drawn seven times over three hours while both glucose and insulin are tracked at every point. The shape of those two curves, read together, is one of the earliest reliable signals of insulin resistance, early beta cell strain, and reactive low blood sugar.

What This Panel Reveals

The panel covers three connected questions that no single fasting test can answer. First, how fast your pancreas reacts when sugar hits your bloodstream. The early insulin numbers, especially the 30 and 60 minute readings, capture what researchers call first-phase insulin secretion. A weak early surge is one of the first measurable signs that beta cells are losing capacity.

Second, how much insulin your body needs to clear that sugar. The mid-curve glucose and insulin values together describe insulin sensitivity. Two people can end up with the same 2-hour glucose, but if one needed five times the insulin to get there, only one of them is metabolically healthy.

Third, how cleanly the system shuts off afterward. The 150-minute and 3-hour readings catch late insulin overshoot and reactive low blood sugar. Late hypoglycemia after a sugar load is a recognized pattern in people with high circulating insulin and helps explain post-meal shakiness, hunger, and brain fog that standard testing would miss.

How to Read Your Results Together

The single most useful trick in reading this panel is to look at glucose and insulin side by side at every time point, not in isolation. A normal-looking glucose curve sitting on top of a high insulin curve is the classic early picture of insulin resistance. An analysis of nearly 8,000 of these tests found that around 75 percent of people with normal glucose tolerance still had an abnormal insulin response.

Pattern at the 30 to 60 minute marksWhat it suggests
Normal glucose, very high insulinInsulin resistance with intact beta cell reserve. Earliest stage. Diet and weight changes have the most leverage here.
High glucose, low or flat insulinBeta cell strain. The pancreas is no longer keeping up. Endocrine workup is reasonable.
1-hour glucose at or above 155 mg/dLInternational Diabetes Federation criterion for intermediate hyperglycemia, even if fasting glucose and HbA1c are normal.
Glucose drops below 70 mg/dL at 2 to 3 hours with high earlier insulinReactive low blood sugar pattern. Often explains post-meal energy crashes.

A 1-hour post-load glucose of 209 mg/dL or higher is now considered diagnostic for type 2 diabetes by the International Diabetes Federation, even when the 2-hour value would not qualify. The 1-hour reading has outperformed fasting glucose, HbA1c, and the 2-hour value across decades of prospective studies for predicting both diabetes and cardiovascular events.

What to Do with Your Results

If your glucose curve is normal but your insulin curve is elevated at any time point, treat this as actionable. Diet quality, carbohydrate timing, strength training, sleep, and weight loss in the 5 to 10 percent range are the highest-yield levers, and the panel can be repeated in 6 to 12 months to confirm the curve is flattening.

If the 1-hour glucose is 155 mg/dL or higher, or if your insulin response looks weak rather than excessive, share the result with a clinician familiar with metabolic medicine. A weak insulin response in particular is not lifestyle alone and warrants a workup for beta cell function. Companion tests worth adding include fasting C-peptide, ApoB, hs-CRP, and a liver enzyme panel, since insulin resistance rarely travels alone.

For tracking, retest every 6 to 12 months when actively changing diet, body composition, or starting medication that affects glucose handling. Once curves are stable and healthy, every two to three years is reasonable.

When Results Can Be Misleading

This panel is unusually sensitive to preparation. Eating fewer than 150 grams of carbohydrates per day in the three days before the test can substantially raise the 2-hour glucose, by 20 mg/dL or more in some studies, enough to make a healthy person look prediabetic. A 10 to 12 hour overnight fast, no caffeine, no nicotine, and no vigorous exercise the morning of the test are all required for the curve to mean what it should.

Acute illness, recent steroid use, and significant sleep deprivation in the prior 48 hours also push both glucose and insulin upward and should be allowed to resolve before drawing conclusions. If any of these apply, repeat the panel under cleaner conditions before acting on the results.

Frequently Asked Questions

References

9 studies
  1. Crofts C, Schofield G, Zinn C, Wheldon M, Kraft JDiabetes Research and Clinical Practice2016
  2. Peddinti G, Bergman M, Tuomi T, Groop LThe Journal of Clinical Endocrinology and Metabolism2019